
Sign up to save your podcasts
Or


In the first of a special two part episode, we talk with biotech equity analyst Matthew Harrison about new case projections ahead of fall and flu season.
By Morgan Stanley4.8
12461,246 ratings
In the first of a special two part episode, we talk with biotech equity analyst Matthew Harrison about new case projections ahead of fall and flu season.

1,713 Listeners

977 Listeners

406 Listeners

1,173 Listeners

2,175 Listeners

199 Listeners

686 Listeners

1,044 Listeners

191 Listeners

71 Listeners

80 Listeners

1,573 Listeners

435 Listeners

212 Listeners

118 Listeners

80 Listeners

0 Listeners